BRAF and melanoma: Many driver gene aberrations have been identified in melanoma, including in BRAF, NRAS, NF1, and KIT. These aberrations all activate the mitogen-activated protein kinase (MAPK) pathway, leading to uncontrolled tumor proliferation [2].